Aging device: tau protein transposes the telomere fragment into promoter/enhancer to promote gene copy number decrement regulation

02 August 2024, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The reasons for the significant impact of abnormal tau protein phosphorylation and aggregation on Alzheimer's disease are still unknown. This study used bioinformatics methods, including protein domain search tools, to investigate the pathogenic mechanism of tau protein in neurodegenerative diseases. The study reveals that tau protein possesses domains linked to the Aging Device. These domains include pyruvate kinase, phosphatase, telomere binding, telomere transposition, HNH cas9, replicon binding, helicase, DNA polymerase, nuclease, transcription factors-like, promoter binding (TATA-box), enhancer binding (Homeobox, MADS-box, HMG box), and mitochondrial localization and mtDNA polymerase. It implies that the tau protein's pyruvate kinase domain supplies ATP energy for its Aging Device function. The HNH Cas9 , reverse transcriptase, and transposase domains cut the sequence between "TAA" from the telomere and then transcript the guide RNA sequence. The transcription factor domain slides to the specific DNA transcription factor binding region. The HNH Cas9 domain excises the intron DNA region complementary to the guide RAN sequence. The transposase and nuclease domains splice the "TAA" from the promoter or enhancer and add the telomere fragment sequence. We thought that tau protein transposes telomere fragments to the promoter/enhancer region might mess up RNA polymerase II, which would help the Aging Device's telomere-guided gene (DNA in the nucleus or mitochondrial) copy number decrement regulation system work better. It can help us understand how stress injuries, like low blood sugar or oxygen levels, can cause tau protein to clump together and phosphorylate, which turns off the Aging Device in a way that doesn't make sense. Thus, the anomalous work of aging devices, such as tau protein, may be associated with neurodegenerative diseases like Alzheimer disease, amyotrophic lateral sclerosis.

Keywords

Phosphorylation
Aggregation
Pyruvate kinase
Telomere transposition
TATA-box
Homeobox
Hypoglycemia/hypoxia

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.